SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-128899
Filing Date
2020-11-24
Accepted
2020-11-24 13:46:58
Documents
1
Effectiveness Date
2020-11-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2037046d1_8k.htm DEFA14A 33046
  Complete submission text file 0001104659-20-128899.txt   34182
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38045 | Film No.: 201342308
SIC: 2834 Pharmaceutical Preparations